|
MechanismHistamine receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date28 Jan 1960 |
100 Clinical Results associated with Undaunted Bio, Inc.
0 Patents (Medical) associated with Undaunted Bio, Inc.
100 Deals associated with Undaunted Bio, Inc.
100 Translational Medicine associated with Undaunted Bio, Inc.